selected publications
- Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. Cancers. 2023 Academic Article GET IT
- The Lack of a Physical Exam During New Patient Telehealth Visits Does Not Impact Plans for Office and Operating Room Procedures. Urology. 2022 Academic Article GET IT
- Biomarkers for prostate cancer detection and risk stratification. Therapeutic advances in urology. 2022 Review GET IT
-
Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series.
Urology.
2022
Academic Article
GET IT
Times cited: 1 -
Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma.
Melanoma management.
2020
Academic Article
GET IT
Times cited: 14 -
Characterization of the Tumor Immune Microenvironment Identifies M0 Macrophage-Enriched Cluster as a Poor Prognostic Factor in Hepatocellular Carcinoma.
JCO clinical cancer informatics.
2020
Academic Article
GET IT
Times cited: 29 -
Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes.
Journal of clinical medicine.
2020
Academic Article
GET IT
Times cited: 13